The Development of Investigator-Initiated Clinical Trials in Surgical Oncology

被引：4
|
作者：
McDonald, Hannah G. [1 ]
Cassim, Emily B. [1 ]
Harper, Megan M. [1 ]
Burke, Erin E. [1 ]
Marcinkowski, Emily F. [1 ]
Cavnar, Michael J. [1 ]
Pandalai, Prakash K. [1 ]
Kim, Joseph [1 ,2 ]
机构：
[1] Univ Kentucky, Div Surg Oncol, 800 Rose St C224, Lexington, KY 40508 USA
[2] Univ Kentucky, Dept Surg, Div Surg Oncol, 800 Rose St, C223, Lexington, KY 40536 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 32卷 / 01期
关键词：
Investigator-initiated trials; Surgical oncology; Clinical trial protocol development; CANCER PATIENTS; LIPOSOMAL IRINOTECAN; AMERICAN SOCIETY; BARRIERS; SURGEONS; FUTURE; NIH;
D O I：
10.1016/j.soc.2022.07.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：13 / 25
页数：13
相关论文
共 50 条
  • [41] Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
    Katharina Klatte
    Suvitha Subramaniam
    Pascal Benkert
    Alexandra Schulz
    Klaus Ehrlich
    Astrid Rösler
    Mieke Deschodt
    Thomas Fabbro
    Christiane Pauli-Magnus
    Matthias Briel
    BMC Medical Research Methodology, 23
  • [42] EXPERIMENTAL THERAPIES Investigator-initiated cancer trials with INDs for approval in Japan
    Imamura, Chiyo K.
    Takebe, Naoko
    Nakamura, Seigo
    Saya, Hideyuki
    Ueno, Naoto T.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (03) : 127 - 128
  • [43] The Dutch Oncology Research Platform (DORP), a national infrastructure for investigator-initiated multicenter clinical cancer research
    Punt, Cornelis J.
    CANCER RESEARCH, 2018, 78 (13)
  • [44] EVOLUTION OF INVESTIGATOR-INITIATED CLINICAL STUDIES IN A HEALTH RESEARCH INSTITUTE
    Llanos, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 50 - 50
  • [45] Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan
    Sato, Yasutaka
    Sakaguchi, Satoshi
    Takechi, Kenshi
    Chuma, Masayuki
    Yagi, Kenta
    Kane, Chikako
    Goda, Mitsuhiro
    Hamano, Hirofumi
    Aoe, Yuki
    Nokihara, Hiroshi
    Kubo, Yoshiaki
    Hashimoto, Ichiro
    Yanagawa, Hiroaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (03) : 374 - 377
  • [46] A program to provide regulatory support for investigator-initiated clinical research
    Arbit, HM
    Paller, MS
    ACADEMIC MEDICINE, 2006, 81 (02) : 146 - 153
  • [47] "It Takes a Village" - investigator-initiated clinical trials in melanoma and non-melanoma skin cancers (NMSCs)
    Paton, Elizabeth
    Diamante, Katrina
    Economides, Alex
    Williams, Narelle
    Shackleton, Mark
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 201 - 202
  • [48] Clinical trials referral resource - Investigator-initiated health-related quality-of-life research
    Rowland, JH
    Varricchio, CG
    Trimble, EL
    Gore-Langton, RE
    ONCOLOGY-NEW YORK, 2001, 15 (10): : 1284 - +
  • [49] THE FREEDOM AND THE RESPONSIBILITY OF INVESTIGATOR-INITIATED RESEARCH
    BROWN, GE
    ACADEMIC MEDICINE, 1994, 69 (06) : 437 - 440
  • [50] INVESTIGATOR-INITIATED RESEARCH - THE PRODUCTIVE PARADOX
    RAUB, WF
    BIOSCIENCE, 1992, 42 (07) : 550 - 555
12345